Avalo Therapeutics Inc. (AVTX)
6.29
-0.23 (-3.53%)
At close: Jan 15, 2025, 3:59 PM
6.32
0.56%
After-hours Jan 15, 2025, 06:08 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -0.08 | -1.14 | -2.1 | -3.01 | -18.94 | -2.8 | 4.96 | -0.47 | -0.71 | n/a | n/a | -93.71 |
| PS Ratio | 1.31 | 2.63 | 32.83 | 28.95 | 45.65 | 6.13 | 2.12 | 6.74 | n/a | n/a | n/a | 11.88K |
| PB Ratio | 0.35 | -4.34 | 7.68 | 7.90 | 14.68 | 5.37 | 2.11 | 37.54 | 0.57 | n/a | n/a | 115.97 |
| P/FCF Ratio | -0.08 | -1.77 | -2.5 | -4.78 | -15.89 | -30.42 | 4.71 | -0.53 | -0.73 | n/a | n/a | -105.69 |
| P/OCF Ratio | -0.08 | -1.77 | -2.5 | -4.78 | -16.1 | -35.91 | 4.71 | -0.53 | -0.73 | n/a | n/a | -105.83 |
| OCF/S Ratio | -15.95 | -1.48 | -13.13 | -6.05 | -2.83 | -0.17 | 0.45 | -12.64 | n/a | n/a | n/a | -112.23 |
| Debt / Equity Ratio | 0.07 | -1.78 | 1.42 | 0.02 | 0.06 | 0.74 | n/a | 11.37 | 0.43 | -0.27 | n/a | n/a |
| Quick Ratio | 1.82 | 0.74 | 3.11 | 1.71 | 1.46 | 0.79 | 0.93 | 1.31 | 3.70 | 2.44 | 1.35 | 6.44 |
| Current Ratio | 1.82 | 0.74 | 3.11 | 1.71 | 1.46 | 0.84 | 0.96 | 1.31 | 3.70 | 2.44 | 1.35 | 6.44 |
| Asset Turnover | 0.09 | 0.54 | 0.07 | 0.15 | 0.19 | 0.26 | 0.64 | 0.20 | n/a | n/a | n/a | 0.01 |
| Interest Coverage | -6.86 | -8.98 | -34.35 | n/a | n/a | n/a | n/a | n/a | -13.88 | -14.19 | -1.23K | n/a |
| Return on Equity (ROE) | -4.32 | 3.82 | -3.65 | -2.62 | -0.77 | -1.92 | 0.43 | -79.57 | -0.8 | 0.61 | 0.73 | -1.24 |
| Return on Assets (ROA) | -1.5 | -1.25 | -1.05 | -1.47 | -0.45 | -0.57 | 0.28 | -2.86 | -0.48 | -1.3 | -2.57 | -1.05 |
| Return on Capital (ROIC) | -1.43 | -3.33 | -1.36 | -0.94 | -0.73 | -0.89 | 0.44 | -11.04 | -0.7 | -2.34 | -6.44 | -1.24 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 33.26% | 80.98% | 72.38% | 95.52% | -72.29% | 59.19% | 97.71% | -614.57% | n/a | n/a | n/a | -10.14K% |
| Net Profit Margin | -1.64K% | -230.78% | -1.56K% | -961.1% | -241.05% | -218.55% | 42.68% | -1.43K% | n/a | n/a | n/a | -12.67K% |
| Pretax Profit Margin | -1.64K% | -230.62% | -1.57K% | -1.00K% | -236.9% | -218.73% | 49.75% | -1.43K% | n/a | n/a | n/a | -12.67K% |
| Operating Profit Margin | -1.22K% | -207.41% | -1.52K% | -402.34% | -257.69% | -214.52% | 49.94% | -1.39K% | n/a | n/a | n/a | -12.68K% |
| FCF Margin | -1.60K% | -148.72% | -1.32K% | -606.1% | -287.35% | -20.15% | 44.93% | -1.27K% | n/a | n/a | n/a | -11.24K% |
| EBITDA Margin | -1.45K% | -206.6% | -1.49K% | -678.47% | -257.2% | -71.32% | 51.58% | -1.39K% | n/a | n/a | n/a | -12.66K% |